AstraZeneca (AZN) Tops Q1 EPS by $1.06

AstraZeneca (NASDAQ: AZN) reported Q1 EPS of $1.89, $1.06 better than the analyst estimate of $0.83. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $10.99 billion.

For earnings history and earnings-related data on AstraZeneca (AZN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c